Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy

Journal of Surgical Oncology
S González-MorenoMarcello Deraco

Abstract

The maximum size of the residual lesions left behind after cytoreductive surgery for peritoneal surface malignancy has consistently been shown to be the main prognostic factor in this setting. However, a uniform assessment method and categorization for this paramount prognostic indicator is lacking. In order to achieve a consensus among experts, the Delphi methodology was employed. Conflicting points were identified and related multiple choice questions were circulated among a panel of experts on peritoneal surface oncology. Two rounds of web-based voting were carried out. The completeness of cytoreduction (CC) Score described by Sugarbaker was considered the current best classification for residual disease size. The experienced surgeon's naked-eye estimation was considered the ideal method to assess residual disease size. There was agreement that the definition of CC-0 or R0 cytoreduction needs further specification. A redefinition of "completeness of cytoreduction" according to disease process was favored by the experts but not favored for the type of intraperitoneal chemotherapy employed. Following the experts' consensus, it is recommended that the CC score be used to categorize residual disease after cytoreductive surgery f...Continue Reading

References

Aug 5, 1995·BMJ : British Medical Journal·J Jones, D Hunter
Jan 1, 1996·Cancer Treatment and Research·P Jacquet, P H Sugarbaker
Jan 6, 2000·Annals of Surgical Oncology·P H Sugarbaker, D Chang
Nov 25, 2000·The British Journal of Surgery·G SebbagP H Sugarbaker
May 4, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A J WitkampF A Zoetmulder
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O GlehenF N Gilly
Feb 3, 2004·Journal of Surgical Oncology·Vic J VerwaalFrans A N Zoetmulder
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O GlehenP Rat
Apr 14, 2005·Annals of Surgical Oncology·Vic J VerwaalFrans A N Zoetmulder

❮ Previous
Next ❯

Citations

Jul 17, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D QuerleuE Leblanc
Jun 27, 2009·The Cancer Journal·Santiago González-MorenoConcepción González-Hernando
Feb 12, 2011·Annals of Surgical Oncology·Pablo Ortega-DeballonPatrick Rat
Dec 19, 2012·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·T WeberK H Link
Mar 1, 2012·Cancer Investigation·Björn L D M BrücherAviram Nissan
Jul 23, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L Gonzalez BayonJ L Garcia Sabrido
Aug 3, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M D KlugerJ A Chabot
Aug 22, 2009·Journal of Surgical Oncology·Aviram NissanPompiliu Piso
Aug 22, 2009·Journal of Surgical Oncology·Santiago González-MorenoLuis González-Bayón
Feb 14, 2015·Acta Obstetricia Et Gynecologica Scandinavica·Jérôme DelotteJean Marc Bereder
Nov 14, 2015·Annals of Surgical Oncology·Paolo SammartinoAngelo Di Giorgio
Dec 5, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Jérôme DelotteJean Marc Bereder
May 17, 2012·World Journal of Gastrointestinal Surgery·Suma L Sangisetty, Thomas J Miner
Feb 23, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I ManzanedoJ Calzas
Sep 6, 2019·Archives of Gynecology and Obstetrics·Nikolaos BlontzosChristos Iavazzo
Jul 13, 2020·Archives of Gynecology and Obstetrics·Dimitrios PapageorgiouIoannis D Kyriazanos
Sep 17, 2020·Annals of Surgical Oncology·Carlos Munoz-ZuluagaArmando Sardi
Jan 31, 2021·International Journal of Molecular Sciences·Matilde ZaballosLuis González-Bayón
Jan 26, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J McGeeUNKNOWN participants of the 5th Ovarian Cancer Consensus Conference

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.